The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.
The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.
复制标题
DOI:
10.1165/rcmb.2009-0250oc
复制
发表时间:
2010-12
影响因子:
6.4
通讯作者:
Davidson DJ
中科院分区:
文献类型:
--
作者:
Barlow PG;Beaumont PE;Cosseau C;Mackellar A;Wilkinson TS;Hancock RE;Haslett C;Govan JR;Simpson AJ;Davidson DJ
Cationic host defence peptides are key, evolutionarily conserved components of the innate immune system. The human cathelicidin LL-37 is an important cationic host defence peptide upregulated in infection and inflammation, including in the human lung, and has been shown to enhance the pulmonary clearance of the opportunistic pathogen Pseudomonas aeruginosa in vivo by as yet undefined mechanisms. In addition to direct microbicidal potential, LL-37 can modulate inflammation and immune mechanisms in host defence against infection, including the capacity to modulate cell death pathways. We demonstrate that at physiologically relevant concentrations of LL-37, this peptide preferentially promoted the apoptosis of infected airway epithelium, via enhanced LL-37-induced mitochondrial membrane depolarisation and release of cytochrome c, with activation of caspases -9 and -3 and induction of apoptosis, which only occurred in the presence of both peptide and bacteria, but not with either stimulus alone. This synergistic induction of apoptosis in infected cells was caspase-dependent, contrasting with the caspase-independent cell death induced by supra-physiological levels of peptide alone. We demonstrate that the synergistic induction of apoptosis by LL-37 and P. aeruginosa required specific bacteria-epithelial cell interaction with whole, live bacteria, and bacterial invasion of the epithelial cell. We propose that LL-37-mediated apoptosis of infected, compromised airway epithelial cells might represent a novel inflammomodulatory role for this peptide in innate host defence, promoting clearance of respiratory pathogens.